Recalcitrant Hypocalcemia: Postsurgical Hypoparathyroidism Exacerbated by a Chyle Leak Treated With Octreotide

Q3 Medicine
Brenda Dorcely MD, Nouran Ibrahim BA, Michael Natter MD, Noah Ziluck, Loren Wissner Greene MD, MA
{"title":"Recalcitrant Hypocalcemia: Postsurgical Hypoparathyroidism Exacerbated by a Chyle Leak Treated With Octreotide","authors":"Brenda Dorcely MD,&nbsp;Nouran Ibrahim BA,&nbsp;Michael Natter MD,&nbsp;Noah Ziluck,&nbsp;Loren Wissner Greene MD, MA","doi":"10.1016/j.aace.2024.01.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Objective</h3><p>To report a case of recalcitrant post-surgical hypocalcemia caused by hypoparathyroidism complicated by a chyle leak and octreotide use.</p></div><div><h3>Case Report</h3><p>A man in his 60s with a 4-month history of voice changes, 10-pound weight loss, and a right-sided neck mass presented with difficulty breathing for 1 week. He had a right laryngeal/hypopharyngeal mass, which was biopsied. Pathology results were positive for invasive squamous cell carcinoma. He underwent an extensive neck surgery, including total thyroidectomy. Postsurgical laboratory results revealed serum corrected calcium of 7.6 mg/dL (ref 8.0-10.2 mg/dL) and parathyroid hormone &lt;6.3 pg/mL (ref. 10-65). Despite treatment with calcium carbonate 12 g (elemental) daily, calcitriol and hydrochlorothiazide, his corrected serum calcium levels remained low. Patient also had a chyle leak that was treated with octreotide. Resolution of his hypocalcemia occurred after substitution of calcium carbonate with calcium citrate, cessation of octreotide, and management of the chyle leak.</p></div><div><h3>Discussion</h3><p>Our patient likely developed recalcitrant hypocalcemia from: 1) postsurgical hypoparathyroidism, 2) a chyle leak, and 3) the use of octreotide. Administration of octreotide to seal the chyle leak most likely decreased gastric acid production and contributed to decrease in absorption of calcium carbonate. Oral calcium citrate may be better absorbed in this case.</p></div><div><h3>Conclusion</h3><p>Postsurgical hypoparathyroidism can lead to hypocalcemia. This case is unique in that the patient’s chyle leak and the use of octreotide contributed to recalcitrant hypocalcemia.</p></div>","PeriodicalId":7051,"journal":{"name":"AACE Clinical Case Reports","volume":"10 2","pages":"Pages 67-70"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2376060524000038/pdfft?md5=9c9e039321433821dc567305cb6014b6&pid=1-s2.0-S2376060524000038-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AACE Clinical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2376060524000038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objective

To report a case of recalcitrant post-surgical hypocalcemia caused by hypoparathyroidism complicated by a chyle leak and octreotide use.

Case Report

A man in his 60s with a 4-month history of voice changes, 10-pound weight loss, and a right-sided neck mass presented with difficulty breathing for 1 week. He had a right laryngeal/hypopharyngeal mass, which was biopsied. Pathology results were positive for invasive squamous cell carcinoma. He underwent an extensive neck surgery, including total thyroidectomy. Postsurgical laboratory results revealed serum corrected calcium of 7.6 mg/dL (ref 8.0-10.2 mg/dL) and parathyroid hormone <6.3 pg/mL (ref. 10-65). Despite treatment with calcium carbonate 12 g (elemental) daily, calcitriol and hydrochlorothiazide, his corrected serum calcium levels remained low. Patient also had a chyle leak that was treated with octreotide. Resolution of his hypocalcemia occurred after substitution of calcium carbonate with calcium citrate, cessation of octreotide, and management of the chyle leak.

Discussion

Our patient likely developed recalcitrant hypocalcemia from: 1) postsurgical hypoparathyroidism, 2) a chyle leak, and 3) the use of octreotide. Administration of octreotide to seal the chyle leak most likely decreased gastric acid production and contributed to decrease in absorption of calcium carbonate. Oral calcium citrate may be better absorbed in this case.

Conclusion

Postsurgical hypoparathyroidism can lead to hypocalcemia. This case is unique in that the patient’s chyle leak and the use of octreotide contributed to recalcitrant hypocalcemia.

顽固性低钙血症:使用奥曲肽治疗因胰液漏而加剧的手术后甲状旁腺功能减退症
背景/目的报告一例因甲状旁腺功能减退症并发糜烂性渗漏和使用奥曲肽而导致的顽固性术后低钙血症。病例报告一名 60 多岁的男性患者有 4 个月的变声史,体重下降 10 磅,右侧颈部肿块,出现呼吸困难 1 周。他的右侧喉部/咽下肿块被活检。病理结果为浸润性鳞状细胞癌。他接受了广泛的颈部手术,包括甲状腺全切除术。手术后的化验结果显示,血清校正钙为 7.6 mg/dL(参考值为 8.0-10.2 mg/dL),甲状旁腺激素为 6.3 pg/mL(参考值为 10-65)。尽管每天服用 12 克元素碳酸钙、降钙素三醇和氢氯噻嗪,他的血清钙校正水平仍然很低。患者还患有糜烂性渗漏,并接受了奥曲肽治疗。在用枸橼酸钙替代碳酸钙、停止使用奥曲肽并处理糜烂渗漏后,患者的低钙血症得到缓解。讨论我们的患者可能是由于以下原因导致顽固性低钙血症:1)手术后甲状旁腺功能减退;2)糜烂渗漏;3)使用奥曲肽。使用奥曲肽封堵糜烂渗漏很可能会减少胃酸分泌,导致碳酸钙吸收减少。在这种情况下,口服枸橼酸钙的吸收效果可能更好。本病例的特殊之处在于,患者的糜烂性渗漏和使用奥曲肽导致了顽固性低钙血症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
AACE Clinical Case Reports
AACE Clinical Case Reports Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.30
自引率
0.00%
发文量
61
审稿时长
55 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信